Downstream bioprocessing steps have long been a challenge to drug manufacturers, particularly the chromatography step for purification of monoclonal antibodies (mAbs). The complexity of traditional ...
Advanced analytics and modeling can be used to predict downstream failures, allowing for corrective action before batches are lost. In the biopharmaceutical industry, quality and consistency are two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results